VG Life Sciences  OTC:VGLS

VG Life Sciences (VGLS) research deploys two technology platforms in the development of transformative therapies to combat drug-sensitive and multi drug-resistant cancers, infectious diseases and autoimmune diseases caused by chronic inflammation. As patient advocates, we are driven by our passion to fulfill an unmet need to treat these pernicious and deadly diseases.

© 2019 by Dynamic Market Concepts

  • Facebook - Black Circle
  • Twitter - Black Circle
  • Google+ - Black Circle